Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long‐term, open‐label safety study-Reference-Cited by-同舟云学术

Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long‐term, open‐label safety study

Published:2021-05-04 Issue:6 Volume:62 Page:1442-1450
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Segal Eric B.¹,Tarquinio Daniel²,Miller Ian³^ORCID,Wheless James W.⁴,Dlugos Dennis⁵,Biton Victor⁶,Cascino Gregory D.⁷,Desai Jay⁸,Hogan R. Edward⁹^ORCID,Liow Kore¹⁰,Sperling Michael R.¹¹^ORCID,Vazquez Blanca¹²,Cook David F.¹³,Rabinowicz Adrian L.¹³,Carrazana Enrique¹³,

Affiliation:

1. Hackensack University Medical Center, Hackensack Meridian School of Health, and Northeast Regional Epilepsy Group Hackensack NJ USA

2. Center for Rare Neurological Diseases Atlanta GA USA

3. Nicklaus Children's Hospital Miami FL USA

4. Le Bonheur Children's Hospital University of Tennessee Health Science Center Memphis TN USA

5. Children's Hospital of Philadelphia Philadelphia PA USA

6. Arkansas Epilepsy Program Little Rock AR USA

7. Mayo Clinic Rochester MN USA

8. Children's Hospital of Los Angeles Los Angeles CA USA

9. Washington University in St. Louis St. Louis MO USA

10. Hawaii Pacific Neuroscience Honolulu HI USA

11. Thomas Jefferson University Philadelphia PA USA